|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics. CA Cancer J Clin. 57:43–66.
2007.
|
|
2
|
Shanta V, Swaminathan R and Kavitha M:
Cancer incidence and mortality in Chennai, India, year 2002. Madras
Metropolitan Tumor Registry, National Cancer Registry Program.
Cancer Institute (WIA); Chennai: 2005
|
|
3
|
Helzlsouer KJ, Harris EL, Parshad R, Perry
HR, Price FM and Sanford KK: DNA repair proficiency: potential
susceptibility factor for breast cancer. J Natl Cancer Inst.
88:754–755. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qiao Y, Spitz MR, Guo Z, Hadeyati M,
Grossman L, Kraemer KH and Wei Q: Rapid assessment of repair of
ultraviolet DNA damage with a modified host-cell reactivation assay
using a luciferase reporter gene and correlation with polymorphisms
of DNA repair genes in normal human lymphocytes. Mutat Res.
509:165–174. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shen MR, Jones IM and Mohrenweiser H:
Nonconservative amino acid substitution variants exist at
polymorphic frequency in DNA repair genes in healthy humans. Cancer
Res. 58:604–608. 1998.PubMed/NCBI
|
|
6
|
Lehmann AR: XPD structure reveals its
secrets. DNA Repair. 7:1912–1915. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
El-Bayoumy K, Chae YH, Upadhyaya P,
Meschter C, Cohen LA and Reddy BS: Inhibition of
7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct
formation in the mammary glands of female Sprague-Dawley rats by
the synthetic organoselenium compound,
1,4-phenylenebis(methylene)selenocyanate. Cancer Res. 52:2402–2407.
1992.
|
|
8
|
Mane SS, Purnell DM and Hsu IC: Genotoxic
effects of five polycyclic aromatic hydrocarbons in human and rat
mammary epithelial cells. Environ Mol Mutagen. 15:78–82. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calaf G and Russo J: Transformation of
human breast epithelial cells by chemical carcinogens.
Carcinogenesis. 14:483–492. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rundle A, Tang D, Hibshoosh H, et al: The
relationship between genetic damage from polycyclic aromatic
hydrocarbons in breast tissue and breast cancer. Carcinogenesis.
21:1281–1289. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li D, Zhang W, Sahin AA and Hittelman WN:
DNA adducts in normal tissue adjacent to breast cancer: a review.
Cancer Detect Prevent. 23:454–462. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kyrtopoulos SA: Biomarkers in
environmental carcinogenesis research: striving for a new momentum.
Toxicol Lett. 15:3–15. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Binkova B, Chvatalova I, Lnenickova Z,
Milcova A, Tulupova E, Farmer PB and Sram RJ: PAH-DNA adducts in
environmentally exposed population in relation to metabolic and DNA
repair gene polymorphisms. Mutat Res. 620:49–61. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Samson M, Swaminathan R, Rama R, Sridevi
V, Nirmala NK and Rajkumar T: Role of GSTM1 (null/present), GSTP1
(Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk
of breast cancer - a case control study from south India. Asian Pac
J Cancer Prev. 8:253–257. 2007.PubMed/NCBI
|
|
15
|
Yarborough A, Zhang YJ, Hsu TM and
Santella RM: Immunoperoxidase detection of 8-hydroxydeoxyguanosine
in aflatoxin B1-treated rat liver and human oral mucosal cells.
Cancer Res. 56:683–688. 1996.PubMed/NCBI
|
|
16
|
Benhamou S and Sarasin A: ERCC2/XPD gene
polymorphisms and cancer risk. Mutagenesis. 17:463–469. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lunn RM, Helzlsouer KJ, Parshad R, Umbach
DM, Harris EL, Sanford KK and Bell DA: XPD polymorphisms: effects
on DNA repair proficiency. Carcinogenesis. 21:551–555. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Terry MB, Gammon MD, Zhang FF, et al:
Polymorphism in the DNA repair gene XPD, polycyclic aromatic
hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.
Cancer Epidemiol Biomarkers Prev. 13:2053–2058. 2004.PubMed/NCBI
|
|
19
|
Tang D, Cho S, Rundle A, et al:
Polymorphisms in the DNA repair enzyme XPD are associated with
increased levels of PAH-DNA adducts in a case-control study of
breast cancer. Breast Cancer Res Treat. 75:159–166. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hou SM, Fält S, Angelini S, Yang K, Nyberg
F, Lambert B and Hemminki K: The XPD variant alleles are associated
with increased aromatic DNA adduct level and lung cancer risk.
Carcinogenesis. 23:599–603. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sturgis EM, Zheng R, Li L, et al:
XPD/ERCC2 polymorphisms and risk of head and neck cancer: a
case-control analysis. Carcinogenesis. 21:2219–2223. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xing D, Tan W, Wei Q and Lin D:
Polymorphisms of the DNA repair gene XPD and risk of lung cancer in
a Chinese population. Lung Cancer. 38:123–129. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Syamala VS, Syamala V, Sreedharan H,
Raveendran PB, Kuttan R and Ankathil R: Contribution of XPD
(Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and
sporadic breast cancer predisposition and survival: an Indian
report. Pathol Oncol Res. 15:389–397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brewster AM, Jorgensen TJ, Ruczinski I, et
al: Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1
(Arg399Gln and Arg194Trp): relationship to breast cancer risk and
familial predisposition to breast cancer. Breast Cancer Res Treat.
95:73–80. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Justenhoven C, Hamann U, Pesch B, et al:
ERCC2 genotypes and a corresponding haplotype are linked with
breast cancer risk in a German population. Cancer Epidemiol
Biomarkers Prev. 13:2059–2064. 2004.PubMed/NCBI
|
|
26
|
Shore RE, Zeleniuch-Jacquotte A, Currie D,
et al: Polymorphisms in XPC and ERCC2 genes, smoking and breast
cancer risk. Int J Cancer. 122:2101–2105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kipikasová L, Wolaschka T, Bohus P, et al:
Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a
case-control study. Pathol Oncol Res. 14:131–135. 2008.PubMed/NCBI
|
|
28
|
Romanowicz-Makowska H, Sobczuk A, Smolarz
B, Fiks T and Kulig A: XPD Lys751Gln polymorphism analysis in women
with sporadic breast cancer. Pol J Pathol. 58:245–249.
2007.PubMed/NCBI
|
|
29
|
Dufloth RM, Costa S, Schmitt F and
Zeferino LC: DNA repair gene polymorphisms and susceptibility to
familial breast cancer in a group of patients from Campinas,
Brazil. Genet Mol Res. 4:771–782. 2005.PubMed/NCBI
|
|
30
|
Zhang L, Zhang Z and Yan W: Single
nucleotide polymorphisms for DNA repair genes in breast cancer
patients. Clin Chim Acta. 359:150–155. 2005. View Article : Google Scholar : PubMed/NCBI
|
